comparemela.com
Home
Live Updates
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update : comparemela.com
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
Cash and cash equivalents totaled €77.8 million as of December 31, 2023Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 millionTopline interim...
Related Keywords
Zurich ,
Züsz ,
Switzerland ,
Paris ,
France General ,
France ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Sakina Sayah Jeanne ,
Tom Huijbers ,
Pascal Prigent ,
Sandra Silvestri ,
Steven Hildemann ,
Drug Administration ,
Phepatology Communications ,
Regulatory Agency ,
Euronext ,
Transition Services Agreement ,
Madrigal Pharmaceuticals ,
Public Accounting Firm ,
Partb Transition Services Agreement ,
European Medicine Agency ,
School Of Engineering ,
Research Translational Science ,
Nasdaq ,
Committee As Executive Vice ,
Research As ,
Exchange Commission ,
Board Of Directors The Company ,
Uncertainties Of The Company ,
Company Annual Shareholder Meeting ,
Primary Biliary ,
Acute On Chronic Liver ,
Biliary Cholangitis ,
Marketing Authorization Application ,
New England Journal ,
Priority Review ,
New Drug Application ,
United Kingdom Medicines ,
Licensing Agreement ,
Chronic Liver Failure ,
Seal Rock Therapeutics ,
Investigational New Drug ,
Hepatology Reports ,
Annual Shareholder Meeting ,
Executive Vice President Research ,
Translational Science ,
Executive Vice President Regulatory ,
Consolidated Financial Statements ,
Independent Registered Public Accounting Firm ,
Urea Cycle Disorders ,
Organic Acidemias ,
Nasdaq Global Select Market ,
Private Securities Litigation Reform Act ,
Registration Document ,
Half Year Business ,
Financial Report ,
Drug User Fee ,
Full Year ,
Provides Corporate ,
Markets ,
comparemela.com © 2020. All Rights Reserved.